Anti-SARS-CoV-2 ORF9b Polyclonal Antibody

Catalog No.

PVV22201

Species reactivity

Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant SARS-CoV-2 ORF9b (Met1-Lys97).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:1000-1:4000

Target

ORF9b protein, ORF9b, Accessory protein 9b, ORF-9b, Protein 9b, 9b

Purification

Purified by antigen affinity column.

Accession

P0DTD2

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Variations of SARS-CoV-2 in the Iranian population and candidate putative drug-like compounds to inhibit the mutated proteins., PMID:35847618

Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections., PMID:35790808

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins., PMID:35216036

Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients., PMID:35116173

Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins., PMID:34242574

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses., PMID:32665645

Document Download

Anti-SARS-CoV-2 ORF9b Polyclonal Antibody.pdf